Appili Therapeutics Inc.
APLIF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,625 | -$3,781 | -$25,118 | -$14,325 |
| Dep. & Amort. | $13 | $14 | $13 | $15 |
| Deferred Tax | $0 | $0 | -$57 | $23 |
| Stock-Based Comp. | $118 | $191 | $875 | $2,040 |
| Change in WC | -$226 | -$999 | $2,487 | $1,642 |
| Other Non-Cash | $3,588 | $2,111 | $1,555 | $23 |
| Operating Cash Flow | $869 | -$2,464 | -$19,081 | -$11,451 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$30 | -$3 | -$8 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$20,010 |
| Inv. Sales/Matur. | $0 | $0 | $5,062 | $15,025 |
| Other Inv. Act. | $0 | $1 | $3 | $5,062 |
| Investing Cash Flow | -$2 | -$29 | $5,062 | -$4,993 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $258 | $204 | $2,414 | $3,829 |
| Stock Issued | $0 | $0 | $3,214 | $5,344 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$65 | -$82 | $280 | $7,845 |
| Financing Cash Flow | $194 | $122 | $9,564 | $17,018 |
| Forex Effect | $74 | $0 | $57 | -$21 |
| Net Chg. in Cash | $1,134 | -$2,371 | -$4,398 | $553 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94 | $2,466 | $11,063 | $10,510 |
| End Cash | $1,228 | $94 | $6,665 | $11,063 |
| Free Cash Flow | $866 | -$2,494 | -$19,084 | -$11,459 |